Clinical trials: Primary Membranous Nephropathy
- Condition Primary Membranous Nephropathy
- Funder type Industry (pharma, biotech, devices)
- Age group Children (under 18)
pMN, IgAN
Atacicept in Multiple Glomerular Diseases
A study to find how well atacicept works and how safe it is in participants with autoimmune kidney disease.
- Conditions
- pMN, IgAN, Nephrotic Syndrome, MCD
- Trial name
- NCT06983028
- Testing
- Atacicept
- Where
- United States
- Volunteers
- 250 people
- Sponsor
- Vera Therapeutics, Inc.